QNRX

Quoin Pharmaceuticals, Ltd. NASDAQ Listed Aug 1, 2016

Healthcare ·Biotechnology ·US · quoinpharma.com

$6.37

After hrs $5.93 +0.00%

Mkt Cap $3.7M

52w Low $5.20 3.2% of range 52w High $41.80

50d MA $7.12 200d MA $9.75

P/E (TTM) 0.0x

EV/EBITDA 233.0x

P/B 0.5x

Debt/Equity 0.0x

ROE -120.5%

P/FCF -0.0x

RSI (14) —

ATR (14) —

Beta 1.82

50d MA $7.12

200d MA $9.75

Avg Volume 100.2K

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

SIC Code

2834

CIK (SEC)

1671502

Phone

703 980 4182

42127 Pleasant Forest Court · Ashburn, VA 20148-7349 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 26, 2026	AMC	-6.42	-14.80	-130.5%	7.57	-2.1%	-15.3%	-17.0%	-12.8%	-19.9%	-7.3%	—
Nov 6, 2025	AMC	-6.36	-6.71	-5.5%	8.57	-0.9%	+5.1%	-5.0%	+34.3%	+41.1%	+56.6%	—
Aug 7, 2025	AMC	-6.83	-6.28	+8.1%	6.91	+1.2%	+3.5%	+2.0%	+3.9%	+3.9%	+5.6%	—
May 13, 2025	AMC	-3.85	-6.50	-68.8%	6.36	+38.8%	+20.3%	+21.1%	+21.1%	+25.6%	+33.2%	—
Mar 13, 2025	AMC	-0.50	-12.24	-2348.0%	10.32	+0.0%	+3.1%	+3.5%	+0.0%	+1.7%	-1.6%	—
Nov 7, 2024	AMC	-15.38	-16.43	-6.8%	24.25	+1.0%	-3.3%	-7.6%	-10.5%	-10.6%	-12.4%	—
Aug 8, 2024	AMC	-26.22	-13.64	+48.0%	18.34	-6.5%	-5.3%	+1.7%	-0.9%	-8.4%	-4.6%	—
May 9, 2024	AMC	-0.76	-38.81	-5006.6%	27.83	-0.6%	-2.8%	-0.8%	-2.2%	-2.4%	-2.4%	—
Mar 13, 2024	AMC	-82.87	-72.73	+12.2%	40.60	-3.4%	-13.8%	-17.5%	-21.6%	-23.3%	-22.4%	—
Nov 8, 2023	AMC	-83.92	-68.18	+18.8%	154.88	+7.1%	-8.3%	-12.5%	-11.0%	-4.0%	-4.0%	—
Aug 2, 2023	AMC	-2.82	-74.48	-2541.1%	246.05	+1.7%	+6.3%	-4.6%	-13.0%	-16.4%	-13.7%	—
May 8, 2023	AMC	-109.13	-142.71	-30.8%	238.56	-3.5%	-14.1%	-15.0%	-15.5%	-14.1%	-14.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 15	Maxim Group	Maintains	Buy → Buy	—	$35.00	$36.05	+3.0%	-4.3%	-9.0%	-11.0%	-10.0%	-10.0%
Sep 7	Alliance Global Partners	Maintains	Buy → Buy	—	$1394.40	$1663.20	+19.3%	+17.8%	+9.6%	+12.0%	+28.3%	+18.4%
May 6	Ladenburg Thalmann	Maintains	Buy → Buy	—	$4247.25	$4830.00	+13.7%	-2.3%	-19.5%	-22.7%	-29.3%	-30.8%
Jan 7	Maxim Group	Maintains	Buy → Buy	—	$9135.00	$10132.50	+10.9%	+19.5%	+6.3%	+10.3%	+6.3%	-4.6%
Dec 15	JMP Securities	Maintains	Market Outperform → Outperform	—	$16695.00	$26722.50	+60.1%	-12.6%	-24.5%	-32.7%	-41.8%	-32.7%

Data updated apr 26, 2026 9:33pm · Source: massive.com